Screener
Summit Therapeutics SMMT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 616,598 | 720,301 |
| Non-current assets: | ||
| Property and equipment, net | 1,664 | 1,059 |
| Operating lease right-of-use assets | 19,398 | 20,616 |
| Goodwill | 1,965 | 2,001 |
| Other assets | 8,231 | 7,205 |
| Total assets | $647,856 | $751,182 |
| Liabilities and stockholders' equity |
Item 1. Financial Statements.
FAQ
- What is Summit Therapeutics's operating lease ROU assets?
- Summit Therapeutics (SMMT) reported operating lease ROU assets of $19.4M in Q1 2026.
- How has Summit Therapeutics's operating lease ROU assets changed year-over-year?
- Summit Therapeutics's operating lease ROU assets increased by 205.4% year-over-year, from $6.35M to $19.4M.
- What is the long-term trend for Summit Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease ROU assets has grown at a 106.1% compound annual growth rate (CAGR), from $554K to $20.62M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Summit Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude